Search results
Jun 19, 2020 · Published online 2020 Jun 19. doi: 10.1055/s-0040-1701658. PMCID: PMC7508636. PMID: 32559806. ADHD: Current Concepts and Treatments in Children and Adolescents. Renate Drechsler, 1 Silvia Brem, 1,2 Daniel Brandeis, 1,2,3,4 Edna Grünblatt, 1,2,4 Gregor Berger, 1 and Susanne Walitza 1,2,4.
- Table - PMC - National Center for Biotechnology Information
Generic name Adverse drug reaction; Methylphenidate...
- The management of ADHD in children and adolescents: bringing ...
Young children: under 5 years (NICE) or under 6 years...
- ADHD in children and youth: Part 1—Etiology, diagnosis, and ...
Current estimates show that 50% of children with ADHD...
- Table - PMC - National Center for Biotechnology Information
Feb 17, 2023 · Results: Twenty-three studies were included, with most rated as “good” quality. Meta-analysis found “very large” effect in both parent- (Hedges’ g −1.67, 95% CI [−2.57, −0.78]) and child-reported (Hedges’ g −1.28, 95% CI [−2.01, −0.56]) HRQoL for children with ADHD compared to children without ADHD.
People also ask
Is there evidence for treatment of ADHD in children and adolescents?
What is the prevalence of ADHD in children and young people?
How effective are pharmacological treatments for children and adolescents with ADHD?
May 21, 2021 · Young children: under 5 years (NICE) or under 6 years (German and Spanish Guidelines); school-aged children: 5/6-18 years; and adults: >18 years. The Dutch guidelines further differentiated between children 6 and 12 and adolescents 12 and 18 years.
- David Coghill, David Coghill, Tobias Banaschewski, Samuele Cortese, Philip Asherson, Daniel Brandeis...
- 2021
Oct 24, 2018 · Current estimates show that 50% of children with ADHD continue to have symptoms of ADHD in adolescence and adulthood. Predictors of persistence include combined inattention/hyperactivity, increased symptom severity, comorbid major depressive or other mood disorder, high comorbidity (>3 additional DSM disorders), parental anxiety, and parental ...
- Stacey A Bélanger, Debbi Andrews, Clare Gray, Daphne Korczak
- 2018
Mar 25, 2024 · Effective treatment of attention-deficit/hyperactivity disorder (ADHD) is essential to improving youth outcomes. OBJECTIVES. This systematic review provides an overview of the available treatment options. DATA SOURCES.
May 23, 2024 · ADHD medication treatment patterns varied by some demographic characteristics; a lower prevalence of children aged 3–5 years were taking ADHD medication (23.6%) than older children (56.9% of children aged 6–11 years, 53.4% of adolescents aged 12–17 years); similarly, Hispanic children and children living in non-English-speaking households ...
This Review comprises a systematic review of the community and administrative prevalence of ADHD in children and adolescents; an overview of the barriers to accessing care; a description of costs associated with ADHD; a discussion of evidence-based pathways and the delivery of clinical care, with consideration of specific issues for two age grou...
